Sign up for the Abwiz Bio Newsletter to get actionable advice and exclusive deals direct to your inbox.
Phospho-Akt1 (Thr308) (G12) rabbit mAb
20 μL is enough antibody for at least 20 Western blots.
Customers Also Viewed
|Description||Akt also known as PKB (Protein kinase B) or RAC-PK (Related to the A and C kinases) is a serine/threonine kinases that contains a pleckstrin homology (PH) domain. This protein kinase is activated by insulin and various growth and survival factors to function in a wortmannin sensitive pathway involving PI3 kinase. Akt is activated by phospholipid binding and activation loop phosphorylation at Thr308 by PDK1 and by phosphorylation within the carboxy terminus at Ser473. Phospho-Akt promotes cell survival by inhibiting apoptosis. Specifically, phospho-Akt1 has been shown to phosphorylate Bad, a member of the Bcl-2 family that promotes cell death. This phosphorylation results in the inactivation of the proapoptotic function of Bad. The Akt/phospho Akt molecule is thus considered to link extracellular survival signals (growth factors) with the apoptotic machinery (BAD). Akt is also a key mediator of the metabolic effects of insulin. Additionally, Akt has been referred to as an oncogene because it has increased activity in a number of tumors. This antibody recognizes phospho Akt phosphorylated at Ser473. This phosphorylation site is shared by all three isoforms of phospho Akt. The homologous phosphorylation sites in Akt2 and Akt3 are S474 and S472, respectively.|
|Please Note||We are currently experiencing technical difficulties with our website that we hope to resolve soon. For order inquiries, please e-mail firstname.lastname@example.org. International shipping is available.|
|Applications||Flow Cytometry, WB|
|Validated Reactivity||Human, Mouse|
|Cross Reactivity||Predicted to work with mouse, rat and other homologues.|
|Immunogen||A synthetic phospho-peptide corresponding to residues surrounding Thr308 of human phospho Akt1|
|Formulation||1X PBS, 0.02% NaN3, 50% Glycerol, 0.1% BSA|
|Recommended Usage||1µg/mL – 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.|
|Pseudonyms||RAC-alpha serine/threonine-protein kinase, Protein kinase B, PKB|
|References||1. Franke TF, et al. (1997) Cell 88: 435-7.
2. Burgering, B.M. and Coffer, P.J. (1995) Nature 376: 599-602.
3.Franke TF, et al. (1995) Cell 81: 727-36.
4. Alessi DR, et al. (1996) EMBO J 15: 6541-51.
5. Sarbassov DD, et al. (2005) Science 307: 1098-101.
6. Jacinto E, et al. (2006) Cell 127: 125-37.
7. Cardone MH, et al. (1998) Science 282: 1318-21.
8. Brunet A, et al. (1999) Cell 96: 857-68.
9. Zimmermann S and Moelling K, (1999) Science 286: 1741-4.
10. Cantley LC and Neel BG (1999) Proc Natl Acad Sci USA 96: 4240-5.
11. Vlahos CJ, et al. (1994) J Biol Chem 269: 5241-8.
12. Hajduch E, et al. (2001) FEBS Lett 492: 199-203.
13. Cross DA, et al. (1995) Nature 378: 785-9.
14. Diehl JA, et al. (1998) Genes Dev 12: 3499-511.
15. Gesbert F, et al. (2000) J Biol Chem 275: 39223-30.
16. Zhou BP, et al. (2001) Nat Cell Biol 3: 245-52.
17. Navé BT, et al. (1999) Biochem J 344: 427-31.
18. Inoki K, et al. (2002) Nat Cell Biol 4: 648-57.
19. Manning BD, et al. (2002) Mol Cell 10: 151-62.
Peptide blocking flow cytometric analysis of K562 cells secondary antibody only negative control (light blue) or treated with LY294002 (red) or with IFNα + IL-4 + pervanadate (green) or LY294002 and blocked with phospho-peptide (black) or IFN+IL4+Pv and blocked with phospho peptide (gold) or LY294002 and blocked with non-phospho peptide (dark blue) or IFN+IL4+Pv and blocked with non-phospho peptide (purple) using Phospho-Akt1 (Thr308) antibody AktT308-G12 at 0.5 µg/mL. Cat. #2286.
Western blot analysis of 293T cell extract untreated or treated with 20% FBS using Phospho-Akt1 (Thr308) antibody AktT308-G12 at 0.1 ug/mL. Cat. #2286.
Western blot analysis of NIH3T3 cell extract untreated or treated with 20% FBS using Phospho-Akt1 (Thr308) antibody AktT308-G12 at 0.1 ug/mL. Cat. #2286.
Flow cytometric analysis of NIH3T3 cells treated with LY294002+U0126+wortmanin and stained with secondary antibody as negative control (blue) or treated with LY294002+U0126+wortmain (red) or with PDGF (green) and stained using Phospho-Akt1 (Thr308) antibody AktT308-G12 at 0.01 µg/mL. Cat. #2286.
Flow cytometric analysis of C6 cells unstained and treated with imatinib as negative control (blue) or treated with imatinib or with PDGF (green) using Phospho-Akt1 (Thr308) antibody AktT308-G12 at 0.01 µg/mL. Cat. #2286.
Phospho-Akt1 (Ser473) (C7) rabbit mAbCatalog#: 1131
Phospho-Akt1 (Ser473) (C7) rabbit mAb PE conjugateCatalog#: 1132
Phospho-Akt1 (Ser473) (C7) rabbit mAb FITC conjugateCatalog#: 1133
Phospho-Akt1 (Ser473) (C7) rabbit mAb APC conjugateCatalog#: 1134